Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ascendis Pharma A/S(ASND) | 10,281,496 | 10,281,496 | 0 | $2.74B | $2.34B | 23.50% | -$399.85M |
| Parabilis Medicines Inc | 28,933,371 | 29,177,964 | +244,593 | $791.91M | $942.16M | 9.45% | +$150.25M |
| Vaxcyte, Inc.(PCVX) | 11,474,599 | 11,474,599 | 0 | $667.02M | $652.90M | 6.55% | -$14.11M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 6,666,837 | 6,666,837 | 0 | $740.22M | $634.78M | 6.37% | -$105.44M |
| Edgewise Therapeutics, Inc.(EWTX) | 8,392,730 | 8,392,730 | 0 | $341.00M | $340.74M | 3.42% | -$251.8K |
| Tyra Biosciences, Inc.(TYRA) | 12,198,625 | 12,198,625 | 0 | $389.62M | $266.78M | 2.68% | -$122.84M |
| Freenome Inc | 0 | 15,367,270 | +15,367,270 | $0 | $242.03M | 2.43% | +$242.03M |
| Hemab Therapeutics Holdings | 7,808,627 | 7,808,627 | 0 | $286.81M | $240.82M | 2.42% | -$45.99M |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 9,550,191 | 9,550,191 | 0 | $323.66M | $232.26M | 2.33% | -$91.40M |
| Septerna, Inc.(SEPN) | 6,995,858 | 5,502,858 | -1,493,000 | $234.29M | $215.33M | 2.16% | -$18.96M |
| SpyGlass Pharma, Inc.(SGP) | 8,021,117 | 8,021,117 | 0 | $178.55M | $208.55M | 2.09% | +$30.00M |
| Janux Therapeutics Inc | 11,189,693 | 11,189,693 | 0 | $171.87M | $193.36M | 1.94% | +$21.48M |
| Mineralys Therapeutics, Inc.(MLYS) | 7,692,750 | 7,692,750 | 0 | $207.55M | $193.32M | 1.94% | -$14.23M |
| Disc Medicine, Inc.(IRON) | 2,450,221 | 2,450,221 | 0 | $179.21M | $160.39M | 1.61% | -$18.82M |
| Taysha Gene Therapies, Inc.(TSHA) | 23,555,648 | 30,435,190 | +6,879,542 | $160.41M | $148.22M | 1.49% | -$12.19M |
| Bicara Therapeutics Inc | 7,255,993 | 7,255,993 | 0 | $215.43M | $135.03M | 1.35% | -$80.40M |
| Artiva Biotherapeutics Inc | 17,955,642 | 18,489,293 | +533,651 | $174.17M | $131.64M | 1.32% | -$42.53M |
| Xencor, Inc.(XNCR) | 5,274,274 | 5,274,274 | 0 | $84.92M | $131.59M | 1.32% | +$46.68M |
| Oruka Therapeutics, Inc.(ORKA) | 1,554,597 | 1,554,597 | 0 | $147.95M | $129.48M | 1.30% | -$18.47M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 4,279,341 | +4,279,341 | $0 | $124.53M | 1.25% | +$124.53M |
| Climb Bio Inc | 11,300,939 | 10,130,130 | -1,170,809 | $147.36M | $116.19M | 1.17% | -$31.17M |
| ABIVAX Société AnonymeADR(ABVX) | 1,132,557 | 1,030,058 | -102,499 | $150.92M | $102.00M | 1.02% | -$48.93M |
| Wave Life Sciences Inc | 0 | 26,975,505 | +26,975,505 | $0 | $99.81M | 1.00% | +$99.81M |
| Latigo Biotherapeutics Inc | 0 | 5,302,933 | +5,302,933 | $0 | $88.56M | 0.89% | +$88.56M |
| Solid Biosciences Inc | 12,036,126 | 12,036,126 | 0 | $120.24M | $87.02M | 0.87% | -$33.22M |
| Vor Biopharma Inc.(VOR) | 2,402,095 | 4,503,882 | +2,101,787 | $44.22M | $85.93M | 0.86% | +$41.71M |
| LB Pharmaceuticals Inc(LBRX) | 2,208,604 | 2,208,604 | 0 | $71.68M | $84.77M | 0.85% | +$13.09M |
| GH Research PLC(GHRS) | 7,636,813 | 3,609,007 | -4,027,806 | $205.28M | $84.74M | 0.85% | -$120.54M |
| Obsidian Therapeutics Inc | 0 | 5,957,103 | +5,957,103 | $0 | $81.79M | 0.82% | +$81.79M |
| Zai Lab LimitedADR(ZLAB) | 5,743,533 | 2,815,543 | -2,927,990 | $109.13M | $74.16M | 0.74% | -$34.97M |
| 4d Molecular Therapeutics In | 5,049,779 | 5,049,779 | 0 | $67.16M | $72.26M | 0.72% | +$5.10M |
| Aclaris Therapeutics Inc | 12,723,026 | 12,723,026 | 0 | $67.30M | $66.92M | 0.67% | -$381.7K |
| Sana Biotechnology Inc | 18,750,000 | 18,750,000 | 0 | $65.44M | $54.66M | 0.55% | -$10.78M |
| Monopar Therapeutics Inc | 667,207 | 667,207 | 0 | $61.78M | $53.16M | 0.53% | -$8.62M |
| Geron Corp | 42,809,751 | 42,754,145 | -55,606 | $54.80M | $52.59M | 0.53% | -$2.21M |
| Damora Therapeutics Inc | 0 | 2,399,702 | +2,399,702 | $0 | $51.07M | 0.51% | +$51.07M |
| Pepgen Inc | 20,064,545 | 20,064,545 | 0 | $36.12M | $48.56M | 0.49% | +$12.44M |
| Ars Pharmaceuticals Inc | 10,860,977 | 10,860,977 | 0 | $87.00M | $46.81M | 0.47% | -$40.19M |
| Acumen Pharmaceuticals Inc | 20,992,669 | 20,992,669 | 0 | $56.05M | $46.60M | 0.47% | -$9.45M |
| Dbv Technologies Sa-Spon Adr | 0 | 3,657,644 | +3,657,644 | $0 | $43.01M | 0.43% | +$43.01M |
| Agenus Inc | 0 | 4,122,000 | +4,122,000 | $0 | $40.93M | 0.41% | +$40.93M |
| Rezolute Inc | 9,445,039 | 9,445,039 | 0 | $49.11M | $39.10M | 0.39% | -$10.01M |
| Sionna Therapeutics Inc | 9,905,045 | 6,456,234 | -3,448,811 | $435.72M | $33.96M | 0.34% | -$401.76M |
| Scribe Therapeutics Inc | 0 | 1,802,178 | +1,802,178 | $0 | $33.17M | 0.33% | +$33.17M |
| Century Therapeutics Inc | 17,754,430 | 17,754,430 | 0 | $43.50M | $30.36M | 0.30% | -$13.14M |
| Evommune Inc | 3,494,638 | 3,494,638 | 0 | $46.44M | $28.87M | 0.29% | -$17.58M |
| Korsana Biosciences Inc | 0 | 892,743 | +892,743 | $0 | $28.57M | 0.29% | +$28.57M |
| Capricor Therapeutics Inc | 1,507,844 | 3,014,183 | +1,506,339 | $36.31M | $28.54M | 0.29% | -$7.76M |
| Nkarta Inc | 10,805,129 | 10,805,129 | 0 | $30.58M | $28.31M | 0.28% | -$2.27M |
| C4 Therapeutics Inc | 8,000,000 | 8,194,779 | +194,779 | $37.36M | $27.29M | 0.27% | -$10.07M |
| Jade Biosciences Inc | 3,671,083 | 1,835,542 | -1,835,541 | $81.57M | $25.79M | 0.26% | -$55.78M |
| Prelude Therapeutics Inc | 6,475,882 | 6,475,882 | 0 | $34.52M | $25.32M | 0.25% | -$9.20M |
| Acrivon Therapeutics Inc | 12,229,396 | 12,229,396 | 0 | $21.77M | $25.07M | 0.25% | +$3.30M |
| Assembly Biosciences Inc | 1,020,410 | 1,020,410 | 0 | $28.04M | $23.97M | 0.24% | -$4.07M |
| Editas Medicine Inc | 8,889,000 | 8,889,000 | 0 | $28.80M | $22.84M | 0.23% | -$5.96M |
| Q32 Bio Inc | 2,332,457 | 2,332,457 | 0 | $29.72M | $19.29M | 0.19% | -$10.43M |
| Anteris Technologies Global | 3,000,000 | 2,474,076 | -525,924 | $29.55M | $19.22M | 0.19% | -$10.33M |
| Electra Therapeutics Inc | 0 | 1,692,965 | +1,692,965 | $0 | $19.05M | 0.19% | +$19.05M |
| Altimmune Inc | 6,500,000 | 6,500,000 | 0 | $19.76M | $18.59M | 0.19% | -$1.17M |
| Benitec Biopharma Inc | 1,850,000 | 1,850,000 | 0 | $24.75M | $18.50M | 0.19% | -$6.25M |
| Alx Oncology Holdings Inc | 13,011,849 | 13,011,849 | 0 | $26.93M | $18.09M | 0.18% | -$8.85M |
| Sagimet Biosciences Inc-A | 0 | 1,800,000 | +1,800,000 | $0 | $17.78M | 0.18% | +$17.78M |
| Lexeo Therapeutics Inc | 5,000,000 | 5,000,000 | 0 | $23.27M | $16.90M | 0.17% | -$6.38M |
| Lenz Therapeutics Inc | 4,178,823 | 4,178,823 | 0 | $23.74M | $16.05M | 0.16% | -$7.69M |
| Aura Biosciences Inc | 2,500,000 | 2,500,000 | 0 | $17.75M | $15.70M | 0.16% | -$2.05M |
| Avalo Therapeutics Inc | 1,000,000 | 1,000,000 | 0 | $18.48M | $15.33M | 0.15% | -$3.15M |
| Inhibikase Therapeutics Inc | 0 | 6,970,000 | +6,970,000 | $0 | $14.32M | 0.14% | +$14.32M |
| Entera Bio Ltd | 0 | 4,901,960 | +4,901,960 | $0 | $14.26M | 0.14% | +$14.26M |
| Seaport Therapeutics Inc | 700,000 | 700,000 | 0 | $15.20M | $14.12M | 0.14% | -$1.08M |
| Sab Biotherapeutics Inc | 4,401,500 | 4,401,500 | 0 | $17.17M | $13.95M | 0.14% | -$3.21M |
| Ovid Therapeutics Inc | 10,500,968 | 5,598,200 | -4,902,768 | $28.25M | $13.94M | 0.14% | -$14.31M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 318,554 | 159,278 | -159,276 | $37.29M | $13.62M | 0.14% | -$23.68M |
| Helix Acquisition Corp-Cl A | 1,250,000 | 1,250,000 | 0 | $13.30M | $13.28M | 0.13% | -$25.0K |
| Bright Minds Biosciences Inc | 265,000 | 265,000 | 0 | $18.60M | $13.20M | 0.13% | -$5.40M |
| Corbus Pharmaceuticals Holdi | 0 | 1,914,788 | +1,914,788 | $0 | $13.06M | 0.13% | +$13.06M |
| Braveheart Bio Inc | 0 | 565,000 | +565,000 | $0 | $11.41M | 0.11% | +$11.41M |
| Onkure Therapeutics Inc-A | 3,998,333 | 3,998,333 | 0 | $18.23M | $10.90M | 0.11% | -$7.34M |
| Palisade Bio Inc | 7,124,116 | 7,124,116 | 0 | $14.89M | $9.62M | 0.10% | -$5.27M |
| Inovio Pharmaceuticals Inc | 0 | 7,220,384 | +7,220,384 | $0 | $8.81M | 0.09% | +$8.81M |
| Macrogenics Inc | 1,864,176 | 1,864,176 | 0 | $8.61M | $7.20M | 0.07% | -$1.42M |
| Rani Therapeutics Holdings-A | 8,500,000 | 8,500,000 | 0 | $6.46M | $6.72M | 0.07% | +$260.1K |
| Adicet Bio Inc | 932,624 | 932,624 | 0 | $8.06M | $6.66M | 0.07% | -$1.40M |
| Tcgx Acquisition Corp-A | 0 | 500,000 | +500,000 | $0 | $6.25M | 0.06% | +$6.25M |
| Faeth Therapeutics Inc | 722,020 | 205,060 | -516,960 | $18.05M | $6.10M | 0.06% | -$11.95M |
| Jatt Ii Acquisition Corp | 500,000 | 500,000 | 0 | $5.68M | $5.62M | 0.06% | -$57.5K |
| Jatt Iii Acquisition Corp | 0 | 450,000 | +450,000 | $0 | $4.96M | 0.05% | +$4.96M |
| Newamsterdam Pharma Co Nv-27WTS *W EXP 99/99/999 | 333,333 | 333,333 | 0 | $7.12M | $4.22M | 0.04% | -$2.91M |
| Amanat Acquisition Corp Cl A | 375,000 | 375,000 | 0 | $3.81M | $4.00M | 0.04% | +$195.0K |
| Equillium Inc | 3,096,336 | 2,317,741 | -778,595 | $9.91M | $3.77M | 0.04% | -$6.14M |
| Sutro Biopharma Inc | 0 | 210,934 | +210,934 | $0 | $3.40M | 0.03% | +$3.40M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 73,607 | +73,607 | $0 | $1.91M | 0.02% | +$1.91M |
| Palatin Technologies Inc | 62,124 | 62,124 | 0 | $670.3K | $551.0K | 0.01% | -$119.3K |
| Aktis Oncology, Inc.(AKTS) | 1,314,405 | 0 | -1,314,405 | $42.36M | $0 | — | -$42.36M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 15,827,186 | 0 | -15,827,186 | $158.27M | $0 | — | -$158.27M |
| BioAge Labs, Inc.(BIOA) | 1,671,648 | 0 | -1,671,648 | $40.97M | $0 | — | -$40.97M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 450,000 | 0 | -450,000 | $6.72M | $0 | — | -$6.72M |
| Definium Therapeutics, Inc.(DFTX) | 1,500,000 | 0 | -1,500,000 | $70.56M | $0 | — | -$70.56M |
| Damora Therapeutics, Inc.(DMRA) | 2,399,702 | 0 | -2,399,702 | $62.42M | $0 | — | -$62.42M |
| Werewolf Therapeutics, Inc.(HOWL) | 2,387,744 | 0 | -2,387,744 | $859.3K | $0 | — | -$859.3K |
| Karyopharm Therapeutics Inc.(KPTI) | 1,917,354 | 0 | -1,917,354 | $18.73M | $0 | — | -$18.73M |